Reference
Eakin CM, et al. Real world experience of poly (ADP-ribose) polymerase inhibitor use in a community oncology practice. Gynecologic Oncology : 15 Aug 2020. Available from: URL: http://doi.org/10.1016/j.ygyno.2020.07.020
Rights and permissions
About this article
Cite this article
Poly(ADP-ribose) polymerase inhibitors: toxicity and costs. PharmacoEcon Outcomes News 861, 30 (2020). https://doi.org/10.1007/s40274-020-7112-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-7112-y